Position in IMUX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$159,692
+$159,598 QoQ
Shares Held
14,387
+79827.8% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMUX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in IMUX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $159,692 | 143,867 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $94 | 178 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $149 | 170 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $725 | 1,040 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $21,326 | 19,566 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,525 | 19,525 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $32,459 | 19,673 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $24,881 | 22,416 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $156,571 | 118,615 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $130,318 | 86,879 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $154,925 | 105,392 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $385,666 | 153,652 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $134,893 | 90,533 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $597,312 | 426,652 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $24,833 | 7,859 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,394 | 5,013 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $98,139 | 8,685 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $125,489 | 13,113 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $55,195 | 6,237 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $65,737 | 5,362 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $84,687 | 5,313 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $189,349 | 12,384 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $130,081 | 7,005 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $125,865 | 10,385 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $15,554 | 2,571 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||